In her role, Rebecca oversees the scientific, strategic, and operational performance of Evidera’s health economics, patient-centered research, and real-world evidence consulting businesses. In this position, she employs her extensive product commercialization and managed markets experience from throughout the United States, Europe, and Asia Pacific to ensure that the value of client products is well supported by relevant and high-quality evidence of value.
Previous business ownership and strong P&L focus have been key factors in the success of Rebecca as part of the executive leadership team at Evidera. She is a results-oriented, analytical leader with proven success in developing and managing high performance, cross-functional teams. Her expertise in business development and strategic planning are strong assets, required to grow profitable businesses in the ever-changing healthcare industry environment.
Prior to joining Evidera, Rebecca was EVP, Global Commercialization in the Advance Insights group at inVentiv Health. Before that she was a partner in her managed markets consulting company Strategyx, LLC. Other professional experiences include Chief Operating Officer at Skila Inc.; Senior Director, Global Project Leader, Neuroscience at Hoechst Marion Roussel; and Manager, Global Research, Advanced Technology Group at Hoechst Celanese Corporation.
Rebecca received her Bachelor of Science degree in chemical engineering from the University of Pittsburgh. She also completed the Hoechst International Management Development Program at IMD, Lausanne, Switzerland.